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Background: Aging is characterized by a low-grade systemic inflammation that contributes to the pathogenesis of
neurodegenerative disorders such as Alzheimer’s disease (AD). However, little knowledge is currently available on
the molecular processes leading to chronic neuroinflammation. In this context, recent studies have described the
role of chromatin regulators in inflammation and longevity including the REST corepressor (Rcor)-2 factor, which
seems to be involved in an inflammatory suppressive program.
Methods: To assess the impact of Rcor2 in age-related inflammation, gene expression levels were quantified in
different tissues and ages of the spontaneous senescence-accelerated P8 mouse (P8) using the SAMR1 mouse (R1)
as a control. Specific siRNA transfection in P8 and R1 astrocyte cultures was used to determine Rcor2 involvement
in the modulation of neuroinflammation. The effect of lipopolysaccharide (LPS) treatment on Rcor2 levels and
neuroinflammation was analyzed both in vivo and in vitro.
Results: P8 mice presented a dramatic decrease in Rcor2 gene expression compared with R1 controls in
splenocytes, an alteration also observed in the brain cortex, hippocampus and primary astrocytes of these mice.
Rcor2 reduction in astrocytes was accompanied by an increased basal expression of the interleukin (Il)-6 gene.
Strikingly, intraperitoneal LPS injection in R1 mice downregulated Rcor2 in the hippocampus, with a concomitant
upregulation of tumor necrosis factor (Tnf-α), Il1-β and Il6 genes. A negative correlation between Rcor2 and Il6
gene expression was also verified in LPS-treated C6 glioma cells. Knock down of Rcor2 by siRNA transfection
(siRcor2) in R1 astrocytes upregulated Il6 gene expression while siRcor2 further increased Il6 expression in P8
astrocytes. Moreover, LPS activation provoked a further downregulation of Rcor2 and an amplified induction of Il6
in siRcor2-tranfected astrocytes.
Conclusions: Data presented here show interplay between Rcor2 downregulation and increased inflammation
and suggest that Rcor2 may be a key regulator of inflammaging.
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The process of aging is associated with a low-grade sys-
temic inflammation defined as inflammaging [1], which
is characterized by an increase of acute-phase circulating
proteins and proinflammatory factors such as interleukin
(IL)-6 and tumor necrosis factor (TNF-α). This condi-
tion has been connected with the onset and evolution of
age-related diseases, including type 2 diabetes mellitus,* Correspondence: pkaliman@ub.edu
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[2-4]. Indeed, the aging brain exhibits a progressive
increase in inflammatory processes [5], which can be
neurotoxic, altering important central functions [6] and
contributing to the pathogenesis of neurodegenerative
disorders such as Alzheimer’s disease (AD) [7]. The
microglia plays a critical role in neuroinflammation as it
represents the main type of immune cells in the brain
[8]. The activation of microglia in aging models leads to
the secretion of proinflammatory cytokines, which con-
tribute to synaptic and neuronal damage as well as cog-
nitive impairment [9,10].entral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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described the role of chromatin regulators in inflammation.
Among them, REST corepressor (RCOR) factor seems to
be involved in an inflammatory suppressive program. In
mammals, two Rcor gene isoforms (Rcor1/CoREST and
Rcor2) have so far been studied. RCOR is found in a com-
plex with the histone demethylase lysine-specific deme-
thylase 1A (KDM1A, previously known as LSD1), which
exhibits nucleosome demethylase activity [11-13], and with
the RE1-silencing transcription factor (REST), which has
been recently associated with cognitive preservation and
longevity [14]. RCOR1/CoREST is involved in the modula-
tion the expression of neuronal genes [15] while RCOR2
plays a role in embryonic stem cells (ESCs) maintenance
and regulation [13]. We have recently shown that knock
down of LSD1/KDM1A or its partner, RCOR2, in pre-
adipocytes results in derepression of an inflammatory pro-
gram with a significant increase in the expression of in-
flammatory genes such as Il6, chemokine ligand 2 (Ccl2),
macrophage proinflammatory protein 1α (Mip1a, also
known as Ccl3), chemokine (C-X-C motif) ligands 5 and
10 (Cxcl5 and Cxcl10), and macrophage activation 2-like
(Mpa2l) [16]. Consistent with these findings, RCOR was
also found to mediate the turnover of nuclear factor kappa
B (NF-κB) and to restore LPS-activated genes to a basal
expression in microglia and astrocytes [17].
Here, we examined the link between Rcor2 and inflam-
mation in the SAMP8 mouse model of accelerated aging
and neurodegeneration. The SAMP8 strain (P8) was se-
lected from AKR/J mice and is a well-characterized model
for studying pathological brain aging [18-21]. The SAMR1
mice (R1), with a similar genetic background and normal
aging characteristics, represent a suitable and widely used
control model [22]. P8 mice presented signs of accelerated
aging such as loss of activity, skin coarseness, alopecia, lack
of hair glossiness, increased lordokyphosis, periophthalmic
lesions, and systemic senile amyloidosis [23]. These mice
also displayed cognitive and behavioral alterations that were
accompanied by molecular features typical of Alzheimer’s
disease (AD), such as overproduction of amyloid-beta pro-
tein, increased tau phosphorylation, cholinergic deficits in
the forebrain and increased oxidative stress [18,19,24-28].
Biomarkers of inflammation such as C-reactive protein and
serum amyloid P are elevated in P8 mice [29].
Here we found that P8 mice present a spontaneous de-
crease in Rcor2 gene expression, which is, at least in part,
responsible for the inflamed phenotype in astrocytes. Our
data show that Rcor2 downregulation and neuroinflamma-
tion are mutually influenced processes.
Materials and methods
Animal care
All experimental procedures were approved by the Ethics
Committee of the Autonomous University of Barcelona(Comissió Ètica d’Experimentació Animal i Humana,
CEEAH, UAB), following the ‘Principles of laboratory ani-
mal care’, and were performed in accordance with the
European Communities Council Directive (86/609/EEC).
SAMP8 and SAMR1 female mice were provided by the
Parc Cientific, (University of Barcelona, Spain) and were
maintained under standard conditions (temperature 23 ±
1°C, humidity 50 to 60%, 12:12-h light-dark cycle, lights
on at 7:00 a.m.), with food (A04, Harlan, Spain) and tap
water available ad libitum throughout the study. Body
weight (g) was measured weekly. For tissue harvesting,
mice were sacrificed by cervical dislocation. The hippo-
campi and cerebral cortices were immediately frozen and
stored at -80°C for further analysis. The spleen was
extracted and sliced, and splenocytes were isolated
through a 70-μm cell strainer (BD Biosciences, San Jose,
CA) in PBS 1X and collected following centrifugation at
1600 rpm for 5 minutes. Erythrocytes were further lysed
using BD Pharm Lyse™ solution (BD Biosciences, San Jose,
CA) at 37°C for 2 min. Cells were recovered by centrifuga-
tion and pellets were aliquoted and frozen at -80°C for fur-
ther analysis.
Lipopolysaccharide treatment and cytokine determination
SAMP8 and SAMR1 mice (males, 12-months old, n = 3/
group) received an intraperitoneal (IP) injection of lipo-
polysaccharide (LPS) (2.9 mg/kg; Sigma-Aldrich, St. Louis,
Mo., USA), or an equal volume of saline. Three hours after
treatment, blood samples were collected and mice were
sacrificed by cervical dislocation. Tissues were collected
and immediately frozen in liquid nitrogen and stored
at -80°C until processed.
Detection of TNF-α, IL1-β and IL6 in plasma was per-
formed by enzyme-linked immunosorbent assay, in ac-
cordance with the protocol provided by the manufacturer
(eBioscience, San Diego, CA; R&D Systems, Minneapolis,
MN and Diaclone, Besançon, France respectively).
Cell culture and transfection
Primary cultures of astrocytes were established from cere-
bral cortical tissue of 2-day-old SAMR1 and SAMP8, as
previously described [30]. Cortices were promptly dis-
sected free of the meninges, diced into small cubes, and
dissociated by incubation for 25 min with a 0.25% trypsin/
1 mM EDTA solution (Gibco-Invitrogen, Carlsbad, CA).
After a further mechanical dissociation, cells were resus-
pended in Dulbecco’s Modified Eagle’s Medium supple-
mented with 2.5 mM glutamine, 100 g/mL gentamycin,
and 20% FBS (Gibco-Invitrogen, Carlsbad, CA). Cells were
seeded at 5×104 cell/cm2 in T75 flasks and incubated at
37°C in a humidified atmosphere of 5% CO2 - 95% air.
The culture medium was changed twice a week. The con-
centration of FBS was changed to 15% and 10% after 1
and 2 weeks of culture, respectively. After 3 weeks, the
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to dislodge microglia and, subsequently, the attached
astrocyte monolayer was collected. This purified fraction
contained more than 90 to 95% of astrocytes, with a minor
fraction of contaminating microglia.
Astrocytes were trypsinized 1 h before transfection, dis-
tributed into 48-well plates (1 × 105 cells/well) and subse-
quently transfected with 60 nM of double-stranded
siRNAs using Metafectene Pro (Biontex, Martinsried,
Germany) at a 1:1 ratio with the siRNA. The sequences of
the siRNAs used were: 5’-GGUCUUGACUCACAGCU
CAtt-3’ (Sense strand) and 5’-UGAGCUGUGAGUCAA
GACCtc-3’ (Antisense strand) for siRCOR2; and Silencer™
negative control siRNA #1 (Applied Biosystems, Foster
City, CA) for siC. RNA was extracted 48 h after
transfection.
Rat C6 glioma cells (purchased from the European Col-
lection of Cell Cultures, ECACC) were cultured as mono-
layer and grown in F12/DMEM medium (Gibco-Invitrogen,
Carlsbad, CA) supplemented with 10% fetal bovine serum
(Gibco-Invitrogen, Carlsbad, CA), 1% non essential a/a’s
(Gibco-Invitrogen, Carlsbad, CA), 1/500 gentamicin
(Gibco-Invitrogen, Carlsbad, CA) and maintained at 37°C
and 5% CO2 in a humidified environment.
For each treatment, C6 cells were seeded in a six-well
plate and cultured in F12/DMEM without serum for
12 h prior to stimulation with LPS. Cells were incubated
with LPS (1 μg/ml) for different time periods ranging
from 30 min to 6 h.Total RNA extraction
Total RNA was extracted from frozen tissues through
mirVana™ RNA Isolation Kit (Applied Biosystems, Foster
City, CA) in accordance with the manufacturer’s
instructions.
RNA extraction from astrocytes and C6 cultured cells
was performed using TRIzol™ Reagent (Invitrogen,
Carlsbad, CA) in accordance with the manufacturer’s
protocol.
The yield, purity, and quality of RNA were deter-
mined spectrophotometrically (Nano-drop Technologies,
Wilmington, DE) and using the Bioanalyzer 2100 capillary
electrophoresis (Agilent Technologies, Palo Alto, CA).
RNA samples with a 260/280 ratio and an RIN higher
than 1.9 and 7.5, respectively, were selected.Real-time quantitative polymerase chain reaction
Random-primed cDNA synthesis was performed at 37°C
starting with 0.3 μg of RNA, using the High Capacity
cDNA Archive kit (Applied Biosystems, Foster City, CA).
Gene expression was measured in an ABI Prism 7900HT
Real Time PCR system using TaqMan FAM labeled spe-
cific probes (Applied Biosystems, , Foster City, CA [seeAdditional file 1]). Results were normalized to the house-
keeping TATA-binding protein (Tbp) gene.
Statistical analysis
The statistical analysis was carried out using the Statistical
Package for Social Sciences (SPSS, version 19.0, www.ibm.
com/software/es/analytics/spss/). An analysis of variance
(ANOVA) was conducted to assess the effects of strain
and specific conditions. Comparisons between groups
were performed by the two-tailed Student’s t-test for
independent samples or the Mann-Whitney U-test as
indicated.
Partial correlation (controlling for time of exposure to
LPS) was used to examine the relationship between Il-6
and Rcor2 expression in the C6 glial cell line.
All values were expressed as mean ± standard error of
the mean. P <0.05 was considered significant. Statistical
outliers (≥two standard deviations from the mean) were
removed from analyses.
Results and discussion
Increased levels of IL6 in serum of P8 mice after
intraperitoneal lipopolysaccharide administration
P8 senescent mice exhibited signs of systemic inflamma-
tion affecting the liver, pancreas, cochlea, bones, testes
and plasma levels of several cytokines and proinflamma-
tory factors [29,31-37]. In addition to their peripheral in-
flamed phenotype, a proinflammatory brain environment
may be involved in the neurodegenerative traits and/or
cognitive deficiency in P8 mice [38]. The inflammatory re-
sponse was analyzed three hours after LPS intraperitoneal
injection in 12 month-old P8 mice and age-matched R1
controls. A pronounced increase was found in IL1β, TNFα
and IL6 serum levels both in P8 and R1 mice in response
to LPS (IL1 β: F(1,7) = 0.962, P <0.05; TNFα: H(3) = 8.389,
P <0.05; IL6: F(1,7) = 67.362, P <0.001) (Figure 1A and B).
Neither strain effect nor interaction between strain and
LPS treatment was observed for IL1β and TNFα cyto-
kines. In contrast, we found both strain and LPS effects
for IL6 (F(1,7) = 12.706, P <0.01; F(1,7) = 67.362, P <0.001)
as well as a strong tendency for interaction between strain
and treatment (P = 0.068). Moreover, IL6 showed in-
creased basal levels in P8 mice (t(3) = −4.139; P <0.05)
(Figure 1C). These data suggest that plasma IL6 could be
an inflammatory biomarker of P8 inflamed phenotype.
Decreased Rcor2 expression in P8 splenocytes, cortex,
hippocampus and astrocytes
We explored the expression of Rcor1 and Rcor2 in P8
mice with the aim of elucidating a possible mechanism
for their inflamed phenotype and increased response to
LPS treatment. We analyzed the Rcor gene expression
pattern in splenocytes from P8 and R1 mice at three dif-
ferent ages: 7 days, 3 months and 9 months. Both strains
Figure 1 Inflammatory response in serum from R1 and P8 mice
after lipopolysaccharide (LPS) administration. (A) Interleukin 1
beta, (B) TNF-α serum levels, (C) Interleukin 6. Cytokine were measured
by ELISA (n = 3/group). Mean ± standard error are represented; Two-way
ANOVA results are indicated as *P <0.05; **P <0.01; ***P <0.001.
Figure 2 Rcor gene expression profile at different ages in
splenocytes from R1 and P8 mice. (A) Rcor1 and (B) Rcor2 gene
expression at the ages of 7 days, 3 months and 9 months (n = 3 to
10/group). Gene expression levels were determined by real time PCR
using TaqMan FAM-labeled specific probes and expressed relative to
Tbp. Mean ± standard error are represented; Two-way ANOVA results
are indicated as *P <0.05; ***P <0.001.
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for Rcor1 with higher levels at 7 days and 9 months
compared with 3 months (F(2,22) = 32.306, P <0.001)
(Figure 2A). In contrast, R1 mice showed an age-
dependent increase in Rcor2 gene expression which was
not observed in P8 mice (interaction between strain and
age: F(2,29) = 4.279, P <0.05) (Figure 2B). Intriguingly, P8
mice exhibited low expression levels of Rcor2 from the
first week of age and throughout the adult life. These dataindicate that Rcor2 underexpression in splenocytes pre-
cedes most of the accelerated-aging characteristics of this
model. Indeed, we found a marked effect for strain and
age in Rcor2 gene expression (F(1,29) = 31.620, P <0.001;
F(2,29) = 3.363, P <0.001; respectively).
Chronic inflammation is associated with early develop-
ment and acceleration of neurodegenerative diseases such
as Alzheimer’s disease [39,40]. Therefore, we analyzed the
expression of Rcor1 and Rcor2 in P8 cortices and hippo-
campi. Rcor1 presented age effect in both cortex and hippo-
campus tissues (F(2,27) = 49.140, P <0.001; F(2,32) = 12.597,
P <0.001; respectively) with a similar age-dependent ex-
pression pattern in both strains (Figure 3A and B). How-
ever, 9-month-old P8 mice, unlike R1 mice, presented
slight but significant alterations in Rcor1 levels in the cor-
tex and in the hippocampus. On the other hand, Rcor2
was expressed similarly in R1 and P8 brain cortices and
hippocampi at 7 days and 3 months of age (Figure 3C
and D).
Remarkably, a consistent characteristic among spleno-
cytes, cortex and hippocampus was that Rcor2 gene ex-
pression in 9-month-old P8 mice decreased significantly
in comparison with R1 controls (cortex: P <0.001; hippo-
campus: P <0.01).
Figure 3 Rcor gene expression profile in brain tissues from R1 and P8 mice. Rcor1 and Rcor2 gene expression was quantified in the cortex
(A and C), in the hippocampus (B and D) at the ages 7 days, 3 months and 9 months (n = 4 to 8/group), and in primary cultured astrocytes
(n = 6 to 9/group) (E and F) from 2 days-old mice. (G) Interleukin 6 basal gene expression levels in primary cultured astrocytes obtained from
2-day-old mice (n = 4/group). Gene expression levels were measured by real time PCR. Mean ± standard error are represented; Two-way ANOVA
results are indicated as *P <0.05; **P <0.01; ***P <0.001.
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Rcor2 in P8 and R1 astrocytes obtained from cerebral
cortical tissue of 2-day-old mice. P8 cells showed similar
Rcor1 but decreased Rcor2 gene expression in com-
parison with R1 cells (t(11) = 5,837; P <0.001) (Figure 3E
and F). Notably, the reduced levels of Rcor2 in P8 com-
pared with R1 astrocytes were accompanied by in-
creased basal levels of Il6 gene expression (t(3) = −4.734;
P = 0.016) (Figure 3G).
These data show that Rcor2 is underexpressed in dif-
ferent tissues and organs in P8 mice and, in some cases
(namely, in splenocytes and astrocytes), this alteration is
detected from early ages. Interestingly, Yankner and
colleagues have recently shown that the transcriptional
repressor REST (RE1-silencing transcription factor) is cru-
cial for neuroprotection during aging [14]. It is known that
REST recruitment of RCOR corepressor is required for its
gene silencing activity [15]. The downregulation of Rcor2
in immune and brain cells of the P8 senescent micestrongly suggests that the accelerated aging in these mice,
as well as their neurodegenerative phenotype, may be re-
lated to Rcor2 deficiency.
On the other hand, RCOR is part of a chromatin remo-
deling complex containing the lysine specific demethylase
(KDM1A), which catalyzes H3 histone demethylation as a
way to repress transcription [12]. In the absence of RCOR,
KDM1A demethylase activity is impaired with a concomi-
tant increase in H3 histone methylation levels. In this con-
text, preliminary data from our group indicate that the
alteration in histone methylation levels is a candidate
mechanism through which Rcor2 could also influence the
aging process in P8 mice. Indeed, P8 mice present
increased levels of trimethylated histone H3 lysine 4
(H3K4me3) in splenocytes, cortex, and hippocampus
(supplementary information, [see Additional file 2A-C]).
Moreover, consistent with a role of Rcor in methylation
signaling and in neuroinflammation, we have found that
Il6 upregulation in response to LPS is significantly
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information, [see Additional file 3]).
Negative correlation between Rcor2 and inflammatory
gene expression after lipopolysaccharide (LPS) treatment
in C6 glioma cells and mouse hippocampus
To approach the possible role of Rcor2 in neuroinflamma-
tion, we first analyzed its gene expression after an in vivo
intraperitoneal LPS injection in 12-month-old P8 and R1
mice. While P8 hippocampus was not further responsive
to the peripheral LPS treatment [see Additional file 4], R1
mice presented a significant decrease in Rcor2 expression
(t(12) = 2.606, P = 0.023) together with an increase in Tnfα,
Il1β and Il6 gene expression levels (t(5.01) = −2.726,
P <0.05; t(5.02) =−2.490, P= 0.055; U(9) = 0.000, Z = −2.449,
P <0.05; respectively) (Figure 4A-D).
A similar effect was found in C6 glioma cells treated
with LPS. C6 cells were activated with LPS for 30 min and
1, 2, 3 and 6 hours. We found a significant reduction inFigure 4 Concomitant downregulation of Rcor2 and increased pro-inf
intraperitoneal lipopolysaccharide (LPS) injection. (A) Rcor2 (B) interleu
in hippocampus from 12 month-old R1 after intraperitoneal lipopolysaccha
and means ± standard errors are represented. Two-way ANOVA results areRcor2 gene expression (F(5,12) = 47.332; P <0.001) with a
concomitant increase in Il6 expression in response to LPS
(F(5,11) = 106.833; P <0.001) (Figure 5A and B, res-
pectively). A significant correlation (controlling for time of
exposure to LPS) was found between IL-6 and Rcor2 ex-
pression (ρr = −0.512 and P = 0.043) (Figure 5C).
Knock down of Rcor2 in astrocytes upregulates Il6 gene
expression
To determine the involvement of Rcor2 in the modulation
of Il6 expression, we knocked down Rcor2 in R1 and P8
astrocytes by transfection of a siRNA to Rcor2 (siRcor2)
using a scrambled siRNA as a control (siC).
Rcor2 knock down led to a 31% and 46% decrease in its
expression levels in R1 and P8 astrocytes, respectively
(F(1,7) = 10.082, P = 0.016) (Figure 6A). Moreover, siRcor2
astrocytes showed increased Il6 levels in both strains with
significantly higher Il6 levels in P8 compared with the R1
cells (strain: F(1,6) = 10.022, P <0.05) (Figure 6B).lammatory gene expression in the R1 hippocampus after
kin 1 beta, (C) tnf-alpha and) (D) interleukin 6 gene expression levels
ride (LPS) injection (n = 5 to 7/group). Real-time PCR was performed
indicated as *P <0.05.
Figure 5 (See legend on next page.)
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Figure 5 Concomitant downregulation of Rcor2 and increased IL6 gene expression in lipopolysaccharide (LPS)-treated C6 glial cell line.
(A) Rcor2 and (B) interleukin 6 gene expression after LPS stimulation (1 μg/ml) in C6 glial cells. Gene expression levels were determined by real-time PCR.
Mean ± standard error from three independent experiments are represented. One-way ANOVA results are indicated as **P <0.01; ***P <0.001. (C) Partial
correlation between Rcor2 and Il6 gene response after LPS treatment in C6 glial cells. P value (P) and partial correlation coefficient (ρr) are indicated.
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the notion that Rcor gene product acts as a repressor of
an inflammatory program [16,17]. Our findings suggest
that Rcor2 underexpression may be at the root of the in-
flamed phenotype that characterizes the P8 strain [29].
Interplay between Rcor2 expression and inflammatory
response in siRcor2 astrocytes
Il6 gene expression was then analyzed in R1 and P8 as-
trocytes transfected with siRcor2 following activation by
LPS and Interferon gamma (IFNγ). Astrocytes from both
strains transfected with scrambled siRNA (siC) were
used as controls.
Notably, LPS/IFNγ treatment further reduced Rcor2 ex-
pression (F(1,14) = 47.465, P <0.001) with a concomitantFigure 6 Knock down of Rcor2 in P8 and R1 astrocytes.
(A) Rcor2 and (B) Interleukin 6 basal gene expression levels after
transfection in P8 and R1 astrocytes of a siRNA to Rcor2 (siRcor2)
using a scrambled siRNA as a control (siC). Gene expression levels
were measured by real-time PCR. Mean ± standard error from three
independent experiments are represented; Two-way ANOVA results
are indicated as *P <0.05.increase in Il6 expression in all conditions tested (siC and
siRcos2 transfected R1 and P8 cells) (F(1,14) = 134.730,
P <0.001) (Figure 7B) (Figure 7A and B, a versus b; c ver-
sus d; f versus e; and g versus h).
For Rcor2, the interaction between strain and LPS/
IFNγ stimulation was also significant (F(1,14) = 16.673,
P <0.01) indicating that the treatment led to a greater
decrease in Rcor2 after LPS/IFNγ stimulation in P8 than
in R1 cells. Il6 expression in response to the stimulus
was significantly exacerbated in siRcor2 knock down as-
trocytes in comparison with siC-transfected cells (trans-
fection X treatment effect: F(1,14) = 11.311, P <0.01)
(Figure 7B, d versus b and h versus f ).
These results suggest that Rcor2 downregulation in
astrocytes induces inflammation and in turn, anFigure 7 Interplay between Rcor2 expression and inflammatory
response in siRcor2 astrocytes. (A) Rcor2 and (B) interleukin 6
gene expression levels after 4.5 h lipopolysaccharide (LPS) (2 μg/ml)
and interferon-gamma (3 μg/ml) stimulation in R1 and P8 astrocytes
transfected with siRNA to Rcor2 (siRcor2) or scrambled siRNA as a
control (siC) (n = 3/group). Gene expression levels were determined
by real-time PCR. Mean ± standard error are represented; Two-way
ANOVA results are indicated as **P <0.01; ***P <0.001.
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We can conclude from our data on transfected astrocytes
that the LPS/INFγ stimulus and Rcor2 knock down repre-
sent independent modulators of Il6 expression and show a
synergic effect when combined.
Conclusions
Little information is currently available on the molecular
triggers of chronic low-grade inflammation, a process
that affects the function of most organs and tissues in-
cluding the central nervous system and is involved in
aging and neurodegeneration [41,42].
RCOR is found in a complex with RE1-silencing tran-
scription factor (REST), which plays a role in protecting
the brain from age-related insults in animal models and
a role in preservation of cognitive function and longevity
in aging humans [14]. Taking into account the early
downregulation of RCOR2 in the P8 mouse model of ac-
celerated aging and neurodegeneration, further studies
are warranted so as to examine whether the REST/
RCOR complex is involved in the shorter lifespan of P8
mice as well as the role of RCOR2 in human cognition
and longevity.
Our study indicates that neuroinflammation is a pa-
thophysiological outcome of Rcor2 downregulation in
the SAMP8 mice. The fact that Rcor2 and Il6 presented
an opposite response after an inflammatory stimulus in
hippocampus and in glial cells, suggests a possible inter-
play between the pathways involved in the regulation of
both genes. This notion is reinforced by our data sho-
wing that Il6 gene is upregulated by Rcor2 knock down
in astrocytes. Therefore, RCOR2 may represent a poten-
tial target for the prevention or treatment of age-related
chronic inflammation and neurodegeneration.
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